Dentsply Sirona Inc (XRAY)
$56.90
0.12 (0.20%)
11:45 EST
XRAY Stock Quote Delayed 15 Minutes
Previous Close
$56.75
Market Cap
12.94B
PE Ratio
-8.53
EPS
-6.67
Volume (Avg. Vol.)
190,554
Day's Range
56.76 - 57.99
52-Week Range
34.93 - 60.15
Dividend & Yield
0.35 (0.61%)
XRAY Stock Predictions, Articles, and Dentsply Sirona Inc News
- From InvestorPlace
- From the Web
3 Big Stock Charts for Monday: Tyson Foods, Nvidia and Dentsply Sirona
Stock charts of NVDA, XRAY and TSN are set to start the new trading week on the verge of key moves.
7 Dental Stocks to Buy That Will Make You Smile
Dental startups have become a hot commodity. Here are seven stocks to buy that are winning in the dental industry.
9 U.S. Stocks That Are Coming to Life Again
All-American U.S. stocks like Foot Locker, Copart and Snapchat are on the mend for all the right reasons. here are the charts to watch.
3 Big Stock Charts for Thursday: Applied Materials, Fortinet and Dentsply Sirona
The stock charts of FTNT, XRAY and AMAT are run through the technical trading wringer. Here's what you should know.
3 Healthcare Stocks That Will Keep Your Portfolio Healthy
These healthcare stocks will benefit from aging baby boomers and improving financials in future quarters.
3 Stock Charts for Wednesday: Dentsply, Procter & Gamble and Valero Energy
The stock charts of XRAY, PG and VLO are headed into the new year on a pretty well-defined path.
7 Healthcare Stocks to Buy Right Now
Healthcare stocks face political uncertainty. However, this mix of 7 buys offers broad diversity, and it profits from the aging of America.
3 Big Stock Charts for Tuesday: Netflix, Unum Group and Dentsply Sirona
Stock charts of NFLX, XRAY and UNM are dropping the most reliable technical hints as we head into a tricky trading environment.
The 10 Most Expensive Stocks In The S&P 500
These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware.
Dentsply Sirona (XRAY) a Sell on Falling Industry Group Rank
Portfolio Grader currently ranks Dentsply Sirona Inc (NASDAQ:XRAY) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking XRAY has had from Portfolio Grader for 2 months.
7 F-Rated Stocks to Sell Before They Get Even Uglier
These seven stocks to sell should be cleared from your portfolio as soon as possible. Here's what you need to know about each.
The 7 Best Low-Risk Healthcare Stocks to Buy
The best healthcare stocks to buy now are those that are safe no matter when the American Health Care Act is passed, or what it looks like.
74 Trades to Make this Week
It pays to stay on top of the latest profit opportunities, and my Portfolio Grader can help inform your trades for the week

Navellier Ratings
Powered by Portfolio GraderTotal Grade
A
Strong Buy